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Differentiation between Mycobacterium tuberculosis and M. avium is essential for the treatment of mycobac-
terial infections. We have developed an easy and rapid detection assay for the diagnosis of mycobacterial dis-
eases. This is a PCR-hybridization assay based on selective amplification of a 16S rRNA gene sequence using pan-
Mycobacterium primers followed by hybridization of the amplification products to biotinylated M. tuberculosis
and M. avium-specific probes. A total of 55 mycobacterial isolates were tested. For all isolates, results concor-
dant with those of conventional identification methods were obtained. Moreover, we developed a method for
extraction of DNA from Ziehl-Neelsen-positive smears which allows the recovery of intact target DNA in our
PCR-hybridization assay. Our method was able to confirm all culture results for 59 Ziehl-Neelsen-positive smears
from clinical specimens (35 sputum, 11 lymph node biopsy, 6 stool, 4 pus, 2 urine, and 1 pericardial fluid spec-
imens). These data suggest that our PCR-hybridization assay, which is simple to perform and less expensive
than commercial probe methods, may be suitable for the identification of M. tuberculosis and M. avium. It could
become a valuable alternative approach for the diagnosis of mycobacterial infections when applied directly to
DNA extracted from Ziehl-Neelsen-positive smears as well.
Since the mid-1980s, mycobacterial infections have become
increasingly widespread for a number of biological and social
reasons, in particular, the human immunodeficiency virus ep-
idemic. Together with the increasing incidence of tuberculosis,
the incidences of Mycobacterium avium diseases and other non-
tuberculous mycobacterial infections have also increased (12,
20, 21). Rapid discrimination between M. tuberculosis and
M. avium is of primary importance for the initiation of a
correct chemotherapeutic regimen, because the two infections
require different types of therapy and management (12, 13, 20).
The advent of PCR has been a breakthrough in the diagnosis
of mycobacterial infections. A number of M. tuberculosis-spe-
cific sequences can now be amplified (3, 5, 10, 11, 18), and dif-
ferent PCR, restriction enzyme analysis, and hybridization
assays have been developed for the diagnosis of M. avium
complex infection (2, 4, 6–8, 16, 17, 22, 24–27, 30, 31). How-
ever, PCR methods are complicated, limited to few mycobac-
terial species, and restricted to research laboratories; in ad-
dition, the high cost of the commercial methods somewhat
hampers the practical use of amplification diagnosis in routine
analysis, mainly for different clinical samples.
The aim of this study was to develop a PCR-hybridization
technique based on the amplification of a 16S rRNA gene se-
quence using pan-Mycobacterium primers followed by hybrid-
ization of the amplification products to M. tuberculosis- and
M. avium-specific probes; this technique may be an alternative
in-house method for species differentiation. Moreover, we
evaluated the possible use of this method in routine mycobac-
teriosis diagnosis of Ziehl-Neelsen-positive smears obtained
from clinical specimens.
MATERIALS AND METHODS
Strains and clinical specimens. The mycobacterial strains (11 American Type
Culture Collection [ATCC] strains and 44 clinical isolates) and the nonmyco-
bacterial strains (4 ATCC strains and 9 clinical isolates) listed in Table 1 were
used to determine the coverage of the pan-Mycobacterium amplification and the
specificity of the M. tuberculosis- and M. avium-specific primers. Hence, 38 acid-
fast-bacillus (AFB)-positive smears from different clinical specimens (18 sputum,
9 lymph node biopsy, 6 stool, 2 pus, 2 urine, and 1 pericardial fluid specimens)
with culture-confirmed infection by M. tuberculosis or M. avium were subse-
quently investigated by PCR-hybridization. Thirty AFB-negative smears (13 spu-
tum, 10 lymph node biopsy, 4 pus, and 3 stool specimens) and 21 AFB-positive
smears (17 sputum, 2 lymph node biopsy, and 2 pus specimens) obtained from
patients affected by mycobacterioses other than those caused by M. tuberculosis
and M. avium were also tested as negative controls (Table 2). Sample decon-
tamination, Ziehl-Neelsen staining, cultural isolation, and identification were
performed by standard methods (14, 15, 29).
Extraction of DNA from cultures and Ziehl-Neelsen-positive smears. Myco-
bacterial DNA was extracted from cultures in accordance with the method de-
scribed by van Embden et al. (28). Stained microscopic preparations were
washed in xylol and absolute ethanol, scraped with a sterile blade, and collected
in a microcentrifuge tube containing phosphate buffer solution. The samples
were centrifuged for 10 min at 13,000 rpm, and pellets were resuspended in 100
ml of lysis buffer (Tris-HCl, 10 mM; KCl, 50 mM; MgCl2, 2.5 mM; Tween 20,
0.45%; Nonidet P-40, 0.45%; proteinase K, 10 mg/ml) and incubated for 3 h at
56°C or overnight at 37°C. The samples were then incubated for 15 min at 95°C
and centrifuged for 15 min at 15,000 3 g, and the supernatants were transferred
to a new microcentrifuge tube and directly used for PCR.
PCR assay. The primers and probes were designed on the basis of the pub-
lished 16S rRNA fragment sequence (2, 22). The first step of the PCR-hybrid-
ization assay was DNA amplification using a pair of pan-Mycobacterium primers
able to amplify all mycobacterial species: M-OU-1 (59-ATAAGCCTGGGAAA
CTGGGT-39 [positions 142 to 162]) and M-OL-2 (59-CACGCTCACAGTTAA
GCCGT-39 [positions 614 to 633]) (Genset, Paris, France). The amplification
was performed in a total volume of 50 ml. The reaction mixture consisted of
5 pmol of primers, 200 mM deoxynucleosides triphosphates (dATP, dCTP, and
dGTP), 190 mM dTTP, 2.5 U of Taq polymerase Gold (Perkin-Elmer, Norwalk,
Conn.), 5 ml of 103 Taq polymerase buffer, 1.5 mM MgCl2, 1 mg of target DNA
(from either cultures or smears), and 10 mM digoxigenin (DIG)-11-dUTP
(Boehringer GmbH, Mannheim, Germany). The cycling parameters were as
follows: 10 cycles of annealing at 58°C for 1 min, elongation at 72°C for 90 s, and
denaturation at 94°C for 1 min; 40 cycles of annealing at 58°C for 30 s, elongation
at 72°C for 40 s, and denaturation at 94°C for 20 s; and a final annealing (58°C
for 1 min) and elongation (72°C for 5 min) step.
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Hybridization assay. After amplification, the DIG-labeled amplified product
was hybridized with two biotinylated probes designed to differentiate between M.
tuberculosis (59-ACCACAAGACATGCATCCCG-39 [positions 182 to 201]) and
M. avium (59-ACCAGAAGACATGCGTCTTG-39 [positions 182 to 201]).
Briefly, streptavidin-coated plates (Labsystems Oy, Helsinki, Finland) were
incubated with a probe at a concentration of 0.1 ng/ml overnight at 4°C. Then, 10
ml of the amplification product was denatured at 98°C for 10 min, diluted in 100
ml of hybridization solution (13 SSC [13 SSC is 0.15 M NaCl plus 0.015 M
sodium citrate], 23 Denhardt’s solution, 1 mM EDTA [pH 8.0], 10 mM Tris [pH
7.5]), and incubated in the wells for 1 h at 50°C. After five washes with 6.7 mM
phosphate buffer (pH 6.4) containing 130 mM NaCl and 0.1% Tween 20, a horse-
radishperoxidase-conjugatedanti-DIGmonoclonalantibody(150mU/ml)(Boehr-
inger) was added, and the plates were incubated for 1 h at room temperature.
Finally, after five washes, the chromogenic substrate (3,39,5,59-tetramethylben-
zidine) was added. The colorimetric reaction was read at 450 nm using a spec-
trophotometer. Optical density values lower than 0.4 were considered negative.
This cutoff value was the mean of negative controls plus 3 standard deviations.
The detection limit of the PCR-hybridization assay, as estimated from serial
dilutions of standard amounts of DNA from M. tuberculosis H37Ra and M. avium
ATCC 15769, varied from 1 pg to 1 fg of mycobacterial DNA and human DNA.
DNA extracted from Ziehl-Neelsen-positive smears was amplified with b-globin
primers PC03 (59-ACACAACTGTGTTCACTACC-39) and PC04 (59-GGTGA
ACGTGGATGAAGTTG-39) as described previously (23) to assess the potential
presence of PCR inhibitors and the integrity of the template DNA. All the ex-
periments were performed in triplicate in order to evaluate reproducibility. Each
PCR-hybridization assay was performed using positive (M. tuberculosis H37Ra
and M. avium ATCC 15769) and negative (human DNA and distilled water)
controls and sterile procedures, following contamination-free guidelines to pre-
vent false-positive results (15). The chance of PCR contamination was minimized
by physical separation of the amplified products from the starting materials, and
all pre-PCR processing of materials took place in a room separate from the PCR
site (which had a circulation-free, sterile bench and UV lighting) (19).
RESULTS
The PCR-hybridization assay was performed on 55 strains
(11 ATCC strains and 44 clinical isolates) of different cultured
mycobacteria (21 M. tuberculosis, 21 M. avium, and 13 other
mycobacterial strains).
Amplification of the 484-bp fragment by pan-Mycobacterium
primers was successful in all 55 mycobacterial isolates. No
amplification of human DNA or DNA from 13 bacterial spe-
cies other than mycobacteria was ever observed under these
conditions, indicating the mycobacterial specificity of the prim-
ers. The M-OU-1 and M-OL-2 primers efficiently amplified
DNA from all mycobacterial isolates, confirming their ability in
the identification of all the Mycobacterium species (Table 1).
The limit of detection of this method was approximately 100 fg
of mycobacterial DNA (Fig. 1). Biotinylated M-TB and M-AV
oligonucleotides, specific for M. tuberculosis and M. avium,
respectively, were used as probes with 10 ml of mycobacterial
DNA amplified with the M-OU-1 and M-OL-2 primers. Twen-
ty-one M. tuberculosis strains were found to be positive when
hybridized with the M. tuberculosis-specific probe (M-TB) and
TABLE 1. PCR amplification of different mycobacterial and
nonmycobacterial species using the pan-Mycobacterium primers
Speciesa No. ofisolates
Pan-Mycobacterium
amplification
resultc
Mycobacterium
M. asiaticum ATCC 25276 1 1
M. avium ATCC 15769 1 1
M. fortuitum ATCC 6841 1 1
M. gordonae ATCC 14470 1 1
M. haemophilum ATCC 43160 1 1
M. intracellulare ATCC 13950 1 1
M. marinum ATCC 11565 1 1
M. phlei ATCC 11758 1 1
M. scrofulaceum ATCC 19981 1 1
M. smegmatis ATCC 19420 1 1
M. tuberculosis ATCC 27294 1 1
M. aviumb 20 1
M. bovisb 1 1
M. chelonaeb 1 1
M. kansasiib 1 1
M. tuberculosisb 20 1
M. xenopib 1 1
Other bacteria and fungusa
Acinetobacter calcoaceticus ATCC 23055 1 2
Citrobacter freundii ATCC 8090 1 2
Enterobacter cloacae ATCC 13047 1 2
Neisseria meningitidis ATCC 13102 1 2
Candida albicansb 1 2
Escherichia colib 1 2
Haemophilus influenzaeb 1 2
Klebsiella pneumoniaeb 1 2
Proteus mirabilisb 1 2
Pseudomonas aeruginosab 1 2
Staphylococcus aureusb 1 2
Staphylococcus epidermidisb 1 2
Streptococcus pneumoniaeb 1 2
a Mycobacterial and bacterial species and a fungus used to determine the
coverage of primers M-OU-1 and M-OL-2.
b Clinical isolates from the University of Milan, Milan, Italy.
c Amplification results were determinated by gel electrophoresis. Symbols: 1,
presence of amplification products; 2, absence of amplification products.
TABLE 2. Comparison of PCR-hybridization assay results with
culture results for the detection of M. tuberculosis and
M. avium from Ziehl-Neelsen-positive smears
Specimen
origin
Ziehl-
Neelsen
resulta
No. of
speci-
mens
Identification
by culture
PCR-hybridization
assay result obtained
with a probe
specific for:
M. tuber-
culosis M. avium
Sputum 11 5 M. tuberculosis Positive Negative
21 1 M. tuberculosis Positive Negative
31 1 M. tuberculosis Positive Negative
41 4 M. tuberculosis Positive Negative
11 5 M. avium Negative Positive
21 1 M. avium Negative Positive
41 1 M. avium Negative Positive
11 1 M. kansasii Negative Negative
21 1 M. kansasii Negative Negative
11 3 M. gordonae Negative Negative
21 4 M. gordonae Negative Negative
11 4 M. xenopi Negative Negative
21 2 M. xenopi Negative Negative
11 1 M. asiaticum Negative Negative
11 1 M. fortuitum Negative Negative
2 13 None Negative Negative
Lymph node 11 5 M. tuberculosis Positive Negative
41 1 M. tuberculosis Positive Negative
11 3 M. avium Negative Positive
21 1 M. scrofulaceum Negative Negative
11 1 M. chelonae Negative Negative
2 10 None Negative Negative
Stool 21 2 M. tuberculosis Positive Negative
21 3 M. avium Negative Positive
41 1 M. avium Negative Positive
2 3 None Negative Negative
Pus 21 2 M. tuberculosis Positive Negative
11 1 M. chelonae Negative Negative
11 1 M. fortuitum Negative Negative
2 4 None Negative Negative
Urine 21 2 M. tuberculosis Positive Negative
Pericardial fluid 31 1 M. tuberculosis Positive Negative
a Clinical specimens were examined by microscopy after Ziehl-Neelsen stain-
ing, and the bacillary index was scored according to the scale of the American
Thoracic Society (29).
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negative when hybridized with the M. avium-specific probe
(M-AV). All 21 M. avium strains generated a positive signal
with the M-AV probe and no signal with the M-TB probe.
There was no cross-hybridization with any of the other myco-
bacterial strains tested, except for M. bovis. No cross-hybrid-
ization with 13 other bacterial species or human chromosomal
DNA was observed (Table 3).
The detection limit of the hybridization assay was 10 fg of
mycobacterial DNA (Fig. 1).
To test the possible use in clinical practice of the PCR-
hybridization assay, 59 Ziehl-Neelsen-positive and 30 Ziehl-
Neelsen-negative smears obtained from clinical samples were
tested in parallel with conventional culturing. Amplification of
the b-globin gene segment was achieved in all 89 samples. PCR
amplification with the M-OU-1 and M-OL-2 primers was suc-
cessful in all of the 59 Ziehl-Neelsen-positive smears. The am-
plified products were hybridized with the DIG-labeled M-TB
and M-AV oligonucleotides. Consistent with the results ob-
tained from culture samples, the hybridization method applied
to clinical specimens was positive exclusively with the corre-
sponding species (specificity, 100%). The same was true for
both microscopically strongly positive and paucibacillary spec-
imens (sensitivity, 100%). The probes did not hybridize to the
amplification products of any other mycobacterial species or
mycobacterial culture-negative specimens. The results are
summarized in Table 2.
DISCUSSION
Differentiation between M. tuberculosis and M. avium is es-
sential for the diagnosis and treatment of mycobacterial infec-
tions in AIDS patients. Cultural isolation and identification of
mycobacterial species usually are performed by time-consum-
ing biochemical tests or by genetic probes, which are quite
expensive. Several molecular genetic methods have also been
recently reported. These include amplification of species-spe-
cific sequences, PCR amplification, restriction enzyme analy-
sis, hybridization with species-specific oligonucleotide probes,
and nucleic acid sequence determination. Thus, PCR methods
could potentially provide very sensitive, specific, and rapid tests
for the detection of mycobacteria. Over the years, several stud-
ies have been published proposing different amplification pro-
tocols directly feasible for clinical specimens, such as sputum,
bronchial washings, and tissue biopsies, mostly for the identi-
fication of M. tuberculosis (1, 3, 9). However, no easy method
is currently available for the detection and identification of
M. tuberculosis and of M. avium. The direct identification of
mycobacterial species is hampered by the poor performance of
the methods and is often possible only in a few reference cen-
ters. Moreover, the wide use of commercial PCR methods still
remains quite expensive for routine analysis, rendering imprac-
tical direct application to all samples based only on clinical
suspicion.
In this study, we propose a simple, in-house nucleic acid
amplification protocol that allows direct detection and species
identification of M. avium and M. tuberculosis (the most rele-
vant mycobacteria in the clinical setting) with DNA extracted
from Ziehl-Neelsen-positive smears.
The good performance of the method that we developed for
the extraction of DNA from smears is evidenced by the main-
tenance of intact template DNA and by the absence of PCR
TABLE 3. Hybridization to various bacterial species of
M. tuberculosis- and M. avium-specific oligonucleotide probes
Bacterial species (n)
No. of specimens with the indicated result
obtained with a probe specific for:
M. avium M. tuberculosis
Positive Negative Positive Negative
M. tuberculosis (21) 0 21 21 0
M. avium (21) 21 0 0 21
Other mycobacteria (12) 0 12 0 12
M. bovis (1) 0 1 1 0
Other bacteria (13) 0 13 0 13
FIG. 1. Detection limit for the PCR-hybridization assay, as estimated from serial dilutions of standard amounts of human DNA and mycobacterial DNA (M.
tuberculosis H37Ra and M. avium ATCC 15769). O.D., optical density.
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inhibitors, as shown by the results for the b-globin internal
control.
Our results show that the PCR-hybridization assay using
M-TB and M-AV as probes specific for M. tuberculosis and
M. avium, respectively, was highly sensitive and specific; cor-
rect identification of M. tuberculosis and M. avium organisms
was achieved in all samples. In fact, 10 fg of nucleic acids,
corresponding to approximately 3 organisms, yielded a clear-
cut positive result. In parallel, the results for Ziehl-Neelsen-
positive smears obtained from clinical specimens (sputum,
lymph node, stool, pus, urine, and pericardial fluid) proved
that our PCR-hybridization assay also allows direct identifica-
tion of M. tuberculosis and M. avium even in paucibacillary
specimens. The applicability of the method directly to DNA
extracted from smears could become a valuable alternative
approach for the routine diagnosis of mycobacterial infections
when used with Ziehl-Neelsen-positive smears.
The PCR-hybridization method with Ziehl-Neelsen-positive
smears coupled the advantage of the amplification techniques
for rapid diagnosis and the concomitant identification of the
different mycobacterial species, allowing the early establish-
ment of the appropriate therapeutic regimens and the prompt
isolation of infected patients.
Our method is relatively simple, rapid, and widely applicable
in experienced clinical laboratories, and the fact that it is
“home brew” means that it is relatively inexpensive. Moreover,
limiting the use of the PCR-hybridization assay only to AFB-
positive smears could reduce both the costs and the probability
of false-positive PCR results. Our assay can be easily per-
formed on stored specimens and therefore can be used in
retrospective studies. The use of different specific probes al-
lows direct etiological diagnosis rather than diagnosis by ex-
clusion, as with the M. tuberculosis probe. In this work, we
designed the two specific probes for the most clinically impor-
tant mycobacterial species but, by using available software
(GenBank), it is also possible to design specific probes within
the 16S rRNA of almost all mycobacterial species and to adapt
the screening panel to the species prevalence in each geo-
graphical area. However, no differentiation between members
of the M. tuberculosis complex can be made, because of the 16S
rRNA homology within these sequences.
Further studies will help to establish whether the PCR-
hybridization technique can also be used to detect and identify
M. tuberculosis and M. avium from particular biological sam-
ples (formalin-fixed, paraffin-embedded tissues) and especially
from blood specimens at an early stage of growth, given the
occurrence of bacteremia observed in immunocompromised
populations, such as human immunodeficiency virus-infected
subjects.
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